RASAL1
ROS1
breast cancer
whole exome sequencing
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
07 Sep 2020
07 Sep 2020
Historique:
received:
16
07
2020
revised:
27
08
2020
accepted:
03
09
2020
entrez:
10
9
2020
pubmed:
11
9
2020
medline:
11
9
2020
Statut:
epublish
Résumé
Breast cancer (BC) is the second leading cause of death in women. BC patients with family history or clinical features suggestive of inherited predisposition are candidate to genetic testing to determine whether a hereditary cancer syndrome is present. We aimed to identify new predisposing variants in familial BC patients using next-generation sequencing approaches. We performed whole exome sequencing (WES) in first-degree cousin pairs affected by hereditary BC negative at the
Identifiants
pubmed: 32906649
pii: cancers12092539
doi: 10.3390/cancers12092539
pmc: PMC7563829
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : ER-Programma Giovani Ricercatori
ID : PRUa1GR-2012-001
Références
Int J Cancer. 2011 Mar 15;128(6):1293-302
pubmed: 20473946
Cancer Res. 2006 Aug 1;66(15):7473-81
pubmed: 16885344
N Engl J Med. 2014 Nov 20;371(21):1963-71
pubmed: 25264305
Front Genet. 2018 Sep 11;9:378
pubmed: 30254663
Int J Cancer. 2018 Oct 1;143(7):1706-1719
pubmed: 29672841
Genomics. 2001 Apr 15;73(2):211-22
pubmed: 11318611
Cancers (Basel). 2017 May 17;9(5):
pubmed: 28513565
Oncol Lett. 2017 Sep;14(3):3839-3845
pubmed: 28927155
Cancer Chemother Pharmacol. 2019 Oct;84(4):679-688
pubmed: 31256210
Nat Rev Genet. 2019 Dec;20(12):747-759
pubmed: 31605095
Oncotarget. 2016 Mar 15;7(11):12289-304
pubmed: 26802023
Cancer Discov. 2017 Apr;7(4):400-409
pubmed: 28183697
Am Soc Clin Oncol Educ Book. 2019 Jan;39:e1-e7
pubmed: 31099622
JAMA Oncol. 2016 Oct 1;2(10):1295-1302
pubmed: 27228256
Nat Genet. 2015 Apr;47(4):373-80
pubmed: 25751625
PLoS Genet. 2012 Sep;8(9):e1002894
pubmed: 23028338
J Clin Endocrinol Metab. 2014 Jul;99(7):E1316-21
pubmed: 24712574
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Br J Cancer. 2006 Dec 4;95(11):1529-36
pubmed: 17088905
Nat Genet. 2015 Jun;47(6):643-6
pubmed: 25915596
J Mol Model. 2009 Mar;15(3):323-8
pubmed: 19057931
Biochim Biophys Acta. 2009 Jan;1795(1):37-52
pubmed: 18778756
Cancer Discov. 2018 Oct;8(10):1227-1236
pubmed: 30093503
Cancer Discov. 2018 Apr;8(4):498-515
pubmed: 29610289
Breast Cancer Res. 2018 Aug 7;20(1):88
pubmed: 30086764
Clin Cancer Res. 2013 Aug 1;19(15):4040-5
pubmed: 23719267
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15984-9
pubmed: 21896743
J Biol Chem. 2015 Oct 2;290(40):24278-93
pubmed: 26269593
Cytokine Growth Factor Rev. 2012 Feb-Apr;23(1-2):15-24
pubmed: 22341689
Hum Mutat. 2008 Dec;29(12):1412-24
pubmed: 18561205
J Clin Oncol. 2019 Feb 20;37(6):453-460
pubmed: 30526229
Yonsei Med J. 2013 May 1;54(3):650-7
pubmed: 23549810
Am J Epidemiol. 2016 Dec 15;184(12):884-893
pubmed: 27923781
Acta Oncol. 2019 Feb;58(2):135-146
pubmed: 30606073
J Natl Cancer Inst. 1995 Nov 15;87(22):1681-5
pubmed: 7473816
Mol Genet Genomic Med. 2015 Jul;3(4):327-45
pubmed: 26247049
FASEB J. 2019 Oct;33(10):11284-11302
pubmed: 31314595
Drugs. 2019 Aug;79(12):1277-1286
pubmed: 31313100
Br J Cancer. 2008 Apr 22;98(8):1457-66
pubmed: 18349832
Mayo Clin Proc. 2019 Aug;94(8):1623-1640
pubmed: 31378236
Clin Cancer Res. 2018 Jul 15;24(14):3334-3347
pubmed: 29636358
Gastroenterology. 2009 Jan;136(1):206-16
pubmed: 18992247
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
Clin Cancer Res. 2016 Dec 15;22(24):5983-5991
pubmed: 27401242
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47
pubmed: 22144499
Am J Hum Genet. 2003 May;72(5):1117-30
pubmed: 12677558
N Engl J Med. 2016 Feb 4;374(5):454-68
pubmed: 26840135
N Engl J Med. 2018 Aug 23;379(8):753-763
pubmed: 30110579
Cell. 2015 Oct 8;163(2):506-19
pubmed: 26451490
Br J Cancer. 2011 Dec 6;105 Suppl 2:S77-81
pubmed: 22158327
J Natl Cancer Inst. 2013 Nov 6;105(21):1617-27
pubmed: 24136889